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Dear Editor,
We thank Dr. K Appelhans et al. for their comments [1]
on our paper [2], published online first in April 2012. In our
review, we aimed to draw the attention of physicians to the
uncontrolled and increasingly alarming use of herbal pro-
ducts and dietary supplements in the general population. In
fact, in Italy this phenomenon, though still limited, has
rapidly increased over the last few years. Here, use of
herbal medicine products has increased to 3.7 %, while in
other countries consumption is higher, reaching 20 % in
the UK, and 40 % in the USA. Young non-smoking women
with a high level of education appear to be the most
common consumers [3]. It seems that women use these
products more than men do, particularly when herbal
products or dietary supplements are used as ‘‘slimming
aids.’’ Many overweight people resort to herbal products
because, in the absence of a strong motivation, conven-
tional methods for losing weight, such as physical exercise
and a low calorie diet, generally fail. Thus, considering
how easy it is to find available dietary supplements or
herbal products via the Internet, people purchase what they
deem the correct preparation directly, without consulting a
physician or pharmacist.
Italian law requires that the labels of these products
include only nutritional and physiological properties;
potential harmful effects are typically not listed. There are
a number of slimming aids and weight loss products
available on the internet, including ones manufactured by
Herbalife, which in the past were also sold door to door.
In our review [2], we listed the Herbalife products in
Table 2. Since 2005, there have been more than 50
reported cases, from a variety of countries, of suspected
hepatoxicity related to Herbalife products, which are often
used as slimming aids. Most of the data regarding these
cases are reported in various issues of the Journal of
Hepatology (we cannot cite them all due to limited space
here in the bibliography). These cases have raised safety
concerns, and an interesting and ongoing debate over the
identification of the presence of one or more hepatotoxic
components. These products are marketed as foods, meal
replacements, and dietary supplements, with different for-
mulations and hundreds of ingredients, among which green
tea extracts and aloe vera, about which there are well-
documented reports of hepatotoxicity, though the labels do
not specify the type of substances (e.g., green tea extracts)
or the amounts of active substances. As also reported by the
manufacturer [1], some formulations are adapted to the
target country or region, and sometimes more than one
product (e.g., weight loss kit) is used simultaneously. As a
result, it is extremely difficult to identify the toxins or
substances responsible for the hepatotoxicity.
We agree with other authors (reference 73 of our
review) that genetic susceptibility might be at the basis
mechanisms of hepatotoxicity, and that some ingredients in
the Herbalife formulations may be responsible for immune-
mediated liver damage that resembles a clinical picture of
autoimmune disease, as has been reported in cases from
Israeli, Swiss and Spain. Considering that there are about
53 reported cases, and Herbalife products are available in
more than 88 markets [1], an idiosyncratic reaction against
one or more ingredients would appear to be a plausible
explanation. Therefore, considering the extreme difficulty
of identifying the essential component(s) responsible for
hepatotoxicity, despite efforts made by the manufacturer to
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cooperate with the regulatory agencies, we correctly stated
that the suspected toxin is still unknown.
In addition, we also stated that a possible cause of
hepatotoxicity linked to Herbalife products is the hypoth-
esis of contamination with Bacillus subtilis in some batches
(reference 77 in our review), and the possible, though still
unproven, contamination of the substrates from which raw
herbs are extracted. This latter possibility is plausible, and
has been linked to other herbal products, such as Kava-
Kava, and the culprit hepatotoxins pipermethystine and
flavokavaine B [4].
Regarding the case series from Israel, Switzerland,
Spain, Argentina and Iceland, Teschke et al. [5] have
addressed a number of the relevant issues concerning the
problem of causality assessment and rechallenge. In our
review, published before these articles were available, we
referred only to the already reported cases identified by
widely used causality assessment scores as probable,
avoiding a discussion of their reliability. The weaker cau-
sality score reassigned, further identification of potential
causative factors, and the evaluation of the rechallenge in
only one of the eight cases already suspected for positive
rechallenge, surely reduce the causality level previously
assigned to the cases involving Herbalife products. They do
not, however, exclude causality for the other patients
reported, identified as suffering from possible Herbalife
product hepatotoxicity.
A greater understanding of these data will, we hope, lead
to awareness in physicians of potential problems, either
when patients disclose the use of these, or even when they
simply express the intention to buy and use them.
Conflict of interest None to declare.
References
1. Appelhans K, Najeeullah R, Frankos V (2014) Considerations
regarding the alleged association between Herbalife products and cases
of hepatotoxicity. Intern Emerg Med. doi:10.1007/s11739-014-1048-9
2. Licata A, Macaluso FS, Craxı` A (2013) Herbal hepatotoxicity: a
hidden epidemic. Intern Emerg Med 8(1):13–22
3. Vitalone A, Menniti-Ippolito F, Moro P, Firenzuoli F, Raschetti R,
Mazzanti G (2011) Suspected adverse reactions associated with
herbal products used for weight loss: a case series reported to the
Italian National Institute of Health. Eur J Clin Pharmacol
67:215–224
4. Teschke RR, Qiu SX, Lebot V (2011) Herbal hepatotoxicity by
kava: update on pipermethystine, flavokavain B, and mould
hepatotoxins as primarily assumed culprits. Dig Liver Dis
43(9):676–681
5. Teschke R, Frenzel C, Schulze J, Schwarzenboeck A, Eickhoff A
(2013) Herbalife hepatotoxicity: evaluation of cases with positive
reexposure tests. World J Hepatol 5(7):353–363
602 Intern Emerg Med (2014) 9:601–602
123
